 | • レポートコード：MRC2303L215 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、251ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に527.3億ドルであった世界の眼科市場規模が2022年に561.1億ドルとなり、2027年までに年平均6.58％拡大して773.1億ドルに達すると予測されています。本書では、眼科の世界市場を対象に総合的に調査・分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、疾患別（加齢性黄斑変性症、白内障、緑内障、炎症性疾患、屈折障害）分析、製品タイプ別（医薬品、機器、処方メガネ＆レンズ、ソフトウェア）分析、エンドユーザー別（医療サービス提供者、病院、医療機関、研究機関）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの構成でまとめております。なお、本書に掲載されている企業情報には、Aerie Pharmaceuticals, Inc.、Alcon Inc.、Alkeus Pharmaceuticals, Inc.、Bausch & Lomb Incorporated、Carl Zeiss AG、ClearSight、CooperVision, Inc.、Essex Bio-Technology Limited、EssilorLuxottica S.A.、Eyenovia, Inc.などが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の眼科市場規模：疾患別 - 加齢性黄斑変性症 - 白内障における市場規模 - 緑内障における市場規模 - 炎症性疾患における市場規模 - 屈折障害における市場規模 ・世界の眼科市場規模：製品タイプ別 - 医薬品の市場規模 - 機器の市場規模 - 処方メガネ＆レンズの市場規模 - ソフトウェアの市場規模 ・世界の眼科市場規模：エンドユーザー別 - 医療サービス提供者における市場規模 - 病院における市場規模 - 医療機関における市場規模 - 研究機関における市場規模 ・世界の眼科市場規模：地域別 - 南北アメリカの眼科市場規模 アメリカの眼科市場規模 カナダの眼科市場規模 ブラジルの眼科市場規模 ... - アジア太平洋の眼科市場規模 日本の眼科市場規模 中国の眼科市場規模 インドの眼科市場規模 韓国の眼科市場規模 台湾の眼科市場規模 ... - ヨーロッパ/中東/アフリカの眼科市場規模 イギリスの眼科市場規模 ドイツの眼科市場規模 フランスの眼科市場規模 ロシアの眼科市場規模 ... - その他地域の眼科市場規模 ・競争状況 ・企業情報 |
The Global Ophthalmology Market size was estimated at USD 52.73 billion in 2021 and expected to reach USD 56.11 billion in 2022, and is projected to grow at a CAGR 6.58% to reach USD 77.31 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Ophthalmology to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Diseases, the market was studied across Age-Related Macular Degeneration, Cataract, Glaucoma, Inflammatory Diseases, and Refractive Disorders.
Based on Product Type, the market was studied across Drugs, Equipment, Prescription Glasses & Lens, and Software. The Drugs is further studied across Allergic Conjunctivitis & Inflammation Drugs, Dry Eye Drugs, Glaucoma Drugs, and Retinal Disorder Drugs. The Equipment is further studied across Diagnostic Devices and Surgical Devices. The Surgical Devices is further studied across Intraocular Lenses and Ophthalmic Lasers.
Based on End User, the market was studied across Healthcare Service Providers, Hospitals, Medical Institutes, and Research Organizations.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Ophthalmology market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Ophthalmology Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Ophthalmology Market, including Aerie Pharmaceuticals, Inc., Alcon Inc., Alkeus Pharmaceuticals, Inc., Bausch & Lomb Incorporated, Carl Zeiss AG, ClearSight, CooperVision, Inc., Essex Bio-Technology Limited, EssilorLuxottica S.A., Eyenovia, Inc., GenSight Biologics S.A., Glaukos Corporation, Hoya Corporation, Iris Pharma, Johnson & Johnson Vision, Kubota Pharmaceutical Holdings Co., Ltd., Nidek Co., Ltd., Oxurion NV, PanOptica, Inc., PharmOptima LLC, Sensimed A.G., Topcon Corporation, Unimed Pharma, Spol. s r.o., Visioncare Optolab Pvt. Ltd., and Wellstat Therapeutics Corporation.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Ophthalmology Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Ophthalmology Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Ophthalmology Market?
4. What is the competitive strategic window for opportunities in the Global Ophthalmology Market?
5. What are the technology trends and regulatory frameworks in the Global Ophthalmology Market?
6. What is the market share of the leading vendors in the Global Ophthalmology Market?
7. What modes and strategic moves are considered suitable for entering the Global Ophthalmology Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Prevalence of Eye Disorders and Growing Awareness Among the Population
5.1.1.2. Emerging Adoption of Prescription Glasses and Lenses
5.1.1.3. Presence of Well-Equipped Healthcare Infrastructure and Increasing Number of Drugs Approvals
5.1.2. Restraints
5.1.2.1. High Cost of Ophthalmologic Treatments
5.1.3. Opportunities
5.1.3.1. Emerging Research Activities of Ophthalmology Treatments and Grants to Support Them
5.1.3.2. Technological Advancements in Ophthalmic Treatments and Devices
5.1.4. Challenges
5.1.4.1. Limited Skilled Professionals for Ophthalmic Procedures
5.2. Cumulative Impact of COVID-19
6. Ophthalmology Market, by Diseases
6.1. Introduction
6.2. Age-Related Macular Degeneration
6.3. Cataract
6.4. Glaucoma
6.5. Inflammatory Diseases
6.6. Refractive Disorders
7. Ophthalmology Market, by Product Type
7.1. Introduction
7.2. Drugs
7.3.1. Allergic Conjunctivitis & Inflammation Drugs
7.3.2. Dry Eye Drugs
7.3.3. Glaucoma Drugs
7.3.4. Retinal Disorder Drugs
7.3. Equipment
7.4.1. Diagnostic Devices
7.4.2. Surgical Devices
7.4.3.1. Intraocular Lenses
7.4.3.2. Ophthalmic Lasers
7.4. Prescription Glasses & Lens
7.5. Software
8. Ophthalmology Market, by End User
8.1. Introduction
8.2. Healthcare Service Providers
8.3. Hospitals
8.4. Medical Institutes
8.5. Research Organizations
9. Americas Ophthalmology Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Ophthalmology Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Ophthalmology Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Aerie Pharmaceuticals, Inc.
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Alcon Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Alkeus Pharmaceuticals, Inc.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Bausch & Lomb Incorporated
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Carl Zeiss AG
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. ClearSight
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. CooperVision, Inc.
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Essex Bio-Technology Limited
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. EssilorLuxottica S.A.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Eyenovia, Inc.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. GenSight Biologics S.A.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Glaukos Corporation
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Hoya Corporation
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Iris Pharma
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Johnson & Johnson Vision
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Kubota Pharmaceutical Holdings Co., Ltd.
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Nidek Co., Ltd.
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Oxurion NV
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. PanOptica, Inc.
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. PharmOptima LLC
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Sensimed A.G.
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Topcon Corporation
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. Unimed Pharma, Spol. s r.o.
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. Visioncare Optolab Pvt. Ltd.
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
13.25. Wellstat Therapeutics Corporation
13.25.1. Business Overview
13.25.2. Key Executives
13.25.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing